Ignite Creation Date:
2024-05-06 @ 2:36 AM
Last Modification Date:
2024-10-26 @ 11:21 AM
Study NCT ID:
NCT02082977
Status:
TERMINATED
Last Update Posted:
2020-02-25
First Post:
2014-01-16
Brief Title:
A Study to Investigate the Safety Pharmacokinetics Pharmacodynamics and Clinical Activity of GSK2816126 in Subjects With RelapsedRefractory Diffuse Large B Cell Lymphoma Transformed Follicular Lymphoma Other Non-Hodgkins Lymphomas Solid Tumors and Multiple Myeloma
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Organization Data
Organization:
GlaxoSmithKline
Class:
INDUSTRY
Study ID:
117208
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
GlaxoSmithKline
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None